title: Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.
abstract: The transporter associated with antigen processing (TAP) and the major histocompatibility complex class I (MHC-I), two important components of the MHC-I antigen presentation pathway, are often deficient in tumor cells. The restoration of their expression has been shown to restore the antigenicity and immunogenicity of tumor cells. However, it is unclear whether TAP and MHC-I expression in tumor cells can affect the induction phase of the T cell response. To address this issue, we expressed viral antigens in tumors that are either deficient or proficient in TAP and MHC-I expression. The relative efficiency of direct immunization or immunization through cross-presentation in promoting adaptive T cell responses was compared. The results demonstrated that stimulation of animals with TAP and MHC-I proficient tumor cells generated antigen specific T cells with greater killing activities than those of TAP and MHC-I deficient tumor cells. This discrepancy was traced to differences in the ability of dendritic cells (DCs) to access and sample different antigen reservoirs in TAP and MHC-I proficient versus deficient cells and thereby stimulate adaptive immune responses through the process of cross-presentation. In addition, our data suggest that the increased activity of T cells is caused by the enhanced DC uptake and utilization of MHC-I/peptide complexes from the proficient cells as an additional source of processed antigen. Furthermore, we demonstrate that immune-escape and metastasis are promoted in the absence of this DC 'arming' mechanism. Physiologically, this novel form of DC antigen sampling resembles trogocytosis, and acts to enhance T cell priming and increase the efficacy of adaptive immune responses against tumors and infectious pathogens.
authors.affiliation: Department of Cellular Biology and Anatomy, Gene Therapy Program, Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA. qzhang@lsuhsc.edu
authors.forename: Qian-Jin
authors.initials: QJ
authors.lastname: Zhang
authors.forename: Xiao-Lin
authors.initials: XL
authors.lastname: Li
authors.forename: David
authors.initials: D
authors.lastname: Wang
authors.forename: Xiao-Cong
authors.initials: XC
authors.lastname: Huang
authors.forename: J Michael
authors.initials: JM
authors.lastname: Mathis
authors.forename: Wei-Ming
authors.initials: WM
authors.lastname: Duan
authors.forename: David
authors.initials: D
authors.lastname: Knight
authors.forename: Runhua
authors.initials: R
authors.lastname: Shi
authors.forename: Jonathan
authors.initials: J
authors.lastname: Glass
authors.forename: Dong-Qing
authors.initials: DQ
authors.lastname: Zhang
authors.forename: Lea
authors.initials: L
authors.lastname: Eisenbach
authors.forename: Wilfred A
authors.initials: WA
authors.lastname: Jefferies